117 related articles for article (PubMed ID: 32365846)
21. Global Analysis of Genes Essential for Francisella tularensis Schu S4 Growth
Ireland PM; Bullifent HL; Senior NJ; Southern SJ; Yang ZR; Ireland RE; Nelson M; Atkins HS; Titball RW; Scott AE
J Bacteriol; 2019 Apr; 201(7):. PubMed ID: 30642993
[TBL] [Abstract][Full Text] [Related]
22. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A
Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332
[TBL] [Abstract][Full Text] [Related]
23. Modern Development and Production of a New Live Attenuated Bacterial Vaccine, SCHU S4
Conlan JW; Sjöstedt A; Gelhaus HC; Fleming P; McRae K; Cobb RR; De Pascalis R; Elkins KL
Pathogens; 2021 Jun; 10(7):. PubMed ID: 34201577
[TBL] [Abstract][Full Text] [Related]
24. ClpB mutants of Francisella tularensis subspecies holarctica and tularensis are defective for type VI secretion and intracellular replication.
Alam A; Golovliov I; Javed E; Sjöstedt A
Sci Rep; 2018 Jul; 8(1):11324. PubMed ID: 30054549
[TBL] [Abstract][Full Text] [Related]
25. Identification of an Attenuated Substrain of
Lovchik JA; Reed DS; Hutt JA; Xia F; Stevens RL; Modise T; Barry EM; Wu TH
Pathogens; 2021 May; 10(6):. PubMed ID: 34067337
[TBL] [Abstract][Full Text] [Related]
26. Roles of reactive oxygen species-degrading enzymes of Francisella tularensis SCHU S4.
Binesse J; Lindgren H; Lindgren L; Conlan W; Sjöstedt A
Infect Immun; 2015 Jun; 83(6):2255-63. PubMed ID: 25802058
[TBL] [Abstract][Full Text] [Related]
27. Control of intracellular Francisella tularensis by different cell types and the role of nitric oxide.
Newstead SL; Gates AJ; Hartley MG; Rowland CA; Williamson ED; Lukaszewski RA
J Immunol Res; 2014; 2014():694717. PubMed ID: 25170518
[TBL] [Abstract][Full Text] [Related]
28. Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4.
Chase JC; Celli J; Bosio CM
Infect Immun; 2009 Jan; 77(1):180-95. PubMed ID: 18981246
[TBL] [Abstract][Full Text] [Related]
29. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
[TBL] [Abstract][Full Text] [Related]
30. Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy.
De Pascalis R; Mittereder L; Kennett NJ; Elkins KL
Infect Immun; 2016 Apr; 84(4):1054-1061. PubMed ID: 26810039
[TBL] [Abstract][Full Text] [Related]
31. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.
Kieffer TL; Cowley S; Nano FE; Elkins KL
Microbes Infect; 2003 Apr; 5(5):397-403. PubMed ID: 12737995
[TBL] [Abstract][Full Text] [Related]
32. The D-alanyl-d-alanine carboxypeptidase enzyme is essential for virulence in the Schu S4 strain of Francisella tularensis and a dacD mutant is able to provide protection against a pneumonic challenge.
Kijek TM; Mou S; Bachert BA; Kuehl KA; Williams JA; Daye SP; Worsham PL; Bozue JA
Microb Pathog; 2019 Dec; 137():103742. PubMed ID: 31513897
[TBL] [Abstract][Full Text] [Related]
33. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
[TBL] [Abstract][Full Text] [Related]
35. Virulence comparison in mice of distinct isolates of type A Francisella tularensis.
Twine SM; Shen H; Kelly JF; Chen W; Sjöstedt A; Conlan JW
Microb Pathog; 2006 Mar; 40(3):133-8. PubMed ID: 16448801
[TBL] [Abstract][Full Text] [Related]
36. Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).
Eyles JE; Hartley MG; Laws TR; Oyston PC; Griffin KF; Titball RW
Microb Pathog; 2008 Feb; 44(2):164-8. PubMed ID: 17904793
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Francisella tularensis Schu S4 mutants identified from a transposon library screened for O-antigen and capsule deficiencies.
Rasmussen JA; Fletcher JR; Long ME; Allen LA; Jones BD
Front Microbiol; 2015; 6():338. PubMed ID: 25999917
[TBL] [Abstract][Full Text] [Related]
38. CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols.
Rozak DA; Gelhaus HC; Smith M; Zadeh M; Huzella L; Waag D; Adamovicz JJ
J Immune Based Ther Vaccines; 2010 Feb; 8(1):2. PubMed ID: 20181102
[TBL] [Abstract][Full Text] [Related]
39. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.
Cowley SC; Elkins KL
J Exp Med; 2003 Aug; 198(3):379-89. PubMed ID: 12885873
[TBL] [Abstract][Full Text] [Related]
40. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
